study	group	count	intervention	measurement_type	substance	tissue	method	time	time_unit	mean	median	min	max	sd	se	cv	unit	comments
Kim2023a	all	28.0	DAP-FOR10	cmax	dapagliflozin	plasma	LC MS/MS	NA	NA	155.07	NA	NA	NA	NA	NA	NA	μg/l	geometric mean
Kim2023a	all	28.0	DAP-FOR10	auc_end	dapagliflozin	plasma	LC MS/MS	48.0	hr	484.72	NA	NA	NA	NA	NA	NA	hr*μg/l	geometric mean
Kim2023a	all	28.0	DAP-FOR10	auc_inf	dapagliflozin	plasma	LC MS/MS	NA	NA	518.61	NA	NA	NA	NA	NA	NA	hr*μg/l	geometric mean
Kim2023a	all	28.0	DAP10	cmax	dapagliflozin	plasma	LC MS/MS	NA	NA	158.79	NA	NA	NA	NA	NA	NA	μg/l	geometric mean
Kim2023a	all	28.0	DAP10	auc_end	dapagliflozin	plasma	LC MS/MS	48.0	hr	494.75	NA	NA	NA	NA	NA	NA	hr*μg/l	geometric mean
Kim2023a	all	28.0	DAP10	auc_inf	dapagliflozin	plasma	LC MS/MS	NA	NA	526.81	NA	NA	NA	NA	NA	NA	hr*μg/l	geometric mean
